Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma have?
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma has 241 citations in the OpenAlex counts ScholarIQ stores.
When was Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma published?
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma has 2009 year in the ScholarIQ index.
What is the open-access status of Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma?
Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma has green oa status in the ScholarIQ index.
What is the DOI of Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma?
The DOI for Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma is on the source record.
What is the PMID of Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma?
The PMID for Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma is on the source record.
What is the OpenAlex record for Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma?
The OpenAlex for Stratified phase II trial of cetuximab in patients with recurrent high-grade glioma is on the source record.